Results
Search Results Summary
Your search results for "Cancer Molecular Diagnostics" are displayed below. Click on the result name for the full record.
| Name | Department | Specimen Type | Sample Container & Volume | Turnaround Time |
|---|---|---|---|---|
| cfDNA Lung T790M mutation | Cancer Molecular Diagnostics | 2 x 8 ml white cell-free DNA collection tubes | 2 x 8ml white cell-free DNA collection tubes (White (K3EDTA plus a cell preservative) After collection invert 8-10 times. | 5 - 10 working days |
| BCR-ABL (p190) | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| BCR-ABL (p210) | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| Chimaerism | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| FLT3-ITD | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| IgH gene rearrangments | Cancer Molecular Diagnostics | Bone Marrow | 3ml in RPMI | 10-15 working days |
| IgH-SoHyMu analysis | Cancer Molecular Diagnostics | Bone Marrow | 3ml in RPMI | 6 weeks |
| JAK2 V617F | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| NPM1 | Cancer Molecular Diagnostics | Bone marrow | 9ml in RPMI | 10-15 working days |
| PML-RARa | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| Post DLI Chimaerism Testing | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| Provenance Analysis | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| RQ BCR-ABL p210 | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| RQ BCR-ABL1 p190 | Cancer Molecular Diagnostics | Bone Marrow | 9ml in RPMI | 10-15 working days |
| t(11;14) | Cancer Molecular Diagnostics | Bone Marrow | 3ml in RPMI | 10-15 working days |
| t(14;18) | Cancer Molecular Diagnostics | Bone Marrow | 3ml in RPMI | 10-15 working days |
| TCR gene rearrangement | Cancer Molecular Diagnostics | Bone Marrow | 3ml in RPMI | 10-15 working days |
| MYD88 L265P mutation | Cancer Molecular Diagnostics | Bone Marrow (preferred) | 9ml in RPMI | 20 working days |
| MPN Panel | Cancer Molecular Diagnostics | Bone Marrow, Peripheral Blood | 9mL in RPMI (Bone Marrow) 9mL in EDTA (Peripheral blood) | 10 -15 working days |
| BRCA - Tumour | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | 20 - 30 working days | |
| Colorectal panel | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | See related links for Solid Tumour Service User Guide | 10 working days |
| GIST panel | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | See related links for Solid Tumour Service User Guide | 10 working days |
| Lung panel | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | See related links for Solid Tumour Service User Guide | 10 working days |
| Melanoma panel | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | See related links for Solid Tumour Service User Guide | 10 working days |
| MYD88 L265P mutation | Cancer Molecular Diagnostics | Formalin fixed paraffin embedded tissue | 20 working days | |
| IgH gene rearrangements | Cancer Molecular Diagnostics | Fresh biopsy | Fresh biopsy in saline dampened gauze | 10-15 working days |
| t(11;14) | Cancer Molecular Diagnostics | Fresh biopsy | Fresh biopsy in saline dampened gauze | 10-15 working days |
| t(14;18) | Cancer Molecular Diagnostics | Fresh biopsy | Fresh biopsy in saline dampened gauze | 10-15 working days |
| TCR gene rearrangements | Cancer Molecular Diagnostics | Fresh Biopsy | Fresh biopsy in saline dampened gauze | 10-15 working days |
| MYD88 L265P mutation | Cancer Molecular Diagnostics | Fresh tissue | Fresh tissue in saline dampened | 20 working days |
| IgH gene rearrangements | Cancer Molecular Diagnostics | Paraffin sections | Paraffin embedded tissue block | 10-15 working days |
| Provenance Analysis | Cancer Molecular Diagnostics | Paraffin Sections | Paraffin block | 10-15 working days |
| t(11;14) | Cancer Molecular Diagnostics | Paraffin Sections | Paraffin embedded block tissue | 10-15 working days |
| t(14;18) | Cancer Molecular Diagnostics | Paraffin Sections | Paraffin embedded tissue block | 10-15 working days |
| TCR gene rearrangements | Cancer Molecular Diagnostics | Paraffin sections | Paraffin embedded tissue blocks | 10-15 working days |
| BCR-ABL (p210) | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in Purple EDTA | 10-15 working days |
| BCR-ABL(p190) | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in Purple EDTA | 10-15 working days |
| BRCA - Germline | Cancer Molecular Diagnostics | Peripheral blood | 3-5ml in Purple EDTA | 20 - 30 working days |
| CALR exon 9 mutations | Cancer Molecular Diagnostics | Peripheral blood | 9ml in Purple EDTA | 10-15 working days |
| Chimaerism | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 10-15 working days |
| FLT3-ITD | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in Purple EDTA | 10-15 working days |
| IgH gene rearrangements | Cancer Molecular Diagnostics | Peripheral Blood | 3ml in purple EDTA | 10-15 working days |
| IgH-SoHyMu analysis | Cancer Molecular Diagnostics | Peripheral Blood | 3ml in purple EDTA | 6 weeks |
| JAK V617F | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in Purple EDTA | 10-15 working days |
| Lineage Specific Chimaerism Test | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in Purple EDTA | 10-15 working days |
| MYD88 L265P mutation | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 20 working days |
| PML-RARa | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 10-15 working days |
| Post DLI Chimaerism Testing | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 10-15 working days |
| Provenance Analysis | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 10-15 working days |
| RQ BCR-ABL p190 | Cancer Molecular Diagnostics | peripheral blood | 9ml in EDTA | 10-15 working days |
| RQ BCR-ABL p210 | Cancer Molecular Diagnostics | Peripheral Blood | 9ml in purple EDTA | 10-15 working days |
| t(11;14) | Cancer Molecular Diagnostics | Peripheral Blood | 3ml in purple EDTA | 10-15 working days |
| t(14;18) | Cancer Molecular Diagnostics | Peripheral Blood | 3ml in purple EDTA | 10-15 working days |
| TCR gene rearrangments | Cancer Molecular Diagnostics | Peripheral Blood | 3ml in purple EDTA | 10-15 working days |
| TP53 mutation analysis | Cancer Molecular Diagnostics | Peripheral blood | 9ml in Purple top EDTA | 6 weeks |
| BRCA - Combined | Cancer Molecular Diagnostics | Peripheral blood & formalin fixed paraffin embedded material | 3-5ml in Purple EDTA | 20-30 working days |
56 results